The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow

Completed · Not applicable · Has a placebo group

Conditions studied: Ocular Blood Flow

In brief

Objectives:To determine LYC-001e's influences on ocular blood flow Ocular blood flow has been implicated as a parameter relevant to eye health and involved in the disease process of several ophthalmic pathologies including AMD, glaucoma, and diabetes We hypothesis that LYC-001e will increase measures of ocular blood flow in healthy individuals Methods: This is a single-phase, randomized, parallel, double blind , comparative study of LYC-001e versus placebo on ocular blood vessels in healthy individuals.

Key facts

Study ID

NCT03068377

Run by

LycoRed Ltd.

People needed

60

Starts

2017-03-20

Expected to finish

2018-12-30

Last updated by the study team

2019-02-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy males and females of 18 years of age or older and free of any eye disease (other than myopia)
• Willing to sign an informed consent statement and able to comply with the requirements of the examination

You may not qualify if…

• Women who are pregnant or lactating or who plan to become pregnant (self reporting) within the duration of the study or within one month after study completion.
• Receiving medications or dietary supplements known to have any interaction with the study supplements.
• Smoker during last ten years (self reporting)
• Concurrent use of any of the components of the study supplement
• Individuals with narrow anterior chamber angles

Where it is running

• Glaucoma Research and Diagnostic Center Eugene and Marilyn Glick Eye Institute Indiana University School of Medicine — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.